Spot Trading’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$2.25M Buy
77,200
+29,300
+61% +$809K 0.04% 667
2017
Q2
$1.33M Buy
47,900
+23,700
+98% +$629K 0.03% 909
2017
Q1
$602K Buy
24,200
+3,000
+14% +$72.9K 0.02% 1119
2016
Q4
$459K Buy
21,200
+10,400
+96% +$227K 0.01% 1461
2016
Q3
$257K Sell
10,800
-45,600
-81% -$1.09M 0.01% 1924
2016
Q2
$1.32M Sell
56,400
-84,000
-60% -$1.82M 0.02% 934
2016
Q1
$2.64M Buy
+140,400
New +$2.47M 0.05% 542
2015
Q4
Sell
-6,500
Closed -$107K 3623
2015
Q3
$107K Buy
+6,500
New +$111K ﹤0.01% 3015
2015
Q2
Sell
-1,600
Closed -$28K 3873
2015
Q1
$28K Sell
1,600
-20,300
-93% -$321K ﹤0.01% 3432
2014
Q4
$290K Sell
21,900
-65,300
-75% -$835K ﹤0.01% 2702
2014
Q3
$1.03M Buy
87,200
+8,900
+11% +$112K 0.01% 2065
2014
Q2
$1M Buy
78,300
+12,400
+19% +$161K ﹤0.01% 2132
2014
Q1
$891K Sell
65,900
-4,200
-6% -$55.1K 0.01% 2112
2013
Q4
$843K Buy
70,100
+31,000
+79% +$366K ﹤0.01% 2092
2013
Q3
$459K Buy
39,100
+26,000
+198% +$281K ﹤0.01% 2485
2013
Q2
$121K Buy
+13,100
New +$111K ﹤0.01% 3361

Other funds holding BSX

Spot Trading's BSX Position: Q3 2017 in Review

Spot Trading increased its Boston Scientific (BSX) stake by 55% in Q3 2017, buying an estimated $364K and bringing the position to 36,949 shares worth $1.08M. The position accounts for 0.02% of the portfolio, ranked #1104.

Spot Trading first reported a position in BSX in Q2 2013 and has held it in 11 quarters since. The position peaked at $1.91M in Q4 2013. 547 funds tracked by Wall St. Rank hold BSX as of Q3 2017.

  • Spot Trading held 36,949 shares of Boston Scientific worth $1.08M as of Q3 2017.
  • Spot Trading bought 13,181 Boston Scientific shares in Q3 2017, an estimated $364K.
  • Boston Scientific made up 0.02% of Spot Trading's portfolio in Q3 2017, its #1104 holding.
  • Spot Trading first reported a position in Boston Scientific in Q2 2013 and has held it in 11 quarters since.
  • Spot Trading's Boston Scientific position peaked at $1.91M in Q4 2013.
  • 547 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.